Google's Gemini 4 Argon model rendered a detailed 40-second 3D animation of a Tesla-style electric motor at less than a quarter of the cost of Anthropic's Claude Opus 5.5. Argon produced 1,200 full HD frames at 30 fps, showcasing its advanced capabilities in coding and spatial reasoning. Priced at half of Opus 5.5's rates for input and output tokens, Argon offers a more cost-effective solution for complex AI tasks. This launch highlights the growing competition in AI models designed for extended, agentic coding and knowledge work.
The story about Gemini 4 Argon's cost-effective 3D animation capabilities is presented with Pluang's cryptocurrency market data as context. For readers following cryptocurrency trends, here is Pluang's market snapshot as of Oct 14, 2026 23:11 WIB: out of 50 major cryptocurrencies, 6 rose and 43 fell. Notable movers include AXS at Rp19.482 with a 1-day change of -4.69% and a Pluang order activity of 94% Sell / 6% Buy, and XLM at Rp3.266 with a 1-day change of -4.56%.
Jefferies has maintained a Buy rating on Big Yellow Group despite recent stock declines, citing the company's strong fundamentals including freehold properties and solid cash flows. Activist investor Ancora, holding over 4% of shares, is pushing Big ...
Fastenal reported strong Q3 2026 earnings, beating analyst expectations with EPS of $0.35 and revenue of $2.46 billion. The company saw a 20% rise in net income to $401.6 million and a 15.5% increase in revenue driven by robust manufacturing demand, ...
Remittix announced the public launch of its RTX token on November 24, 2026, marking the end of its presale phase which raised over $32 million from 40,000 participants. The project is testing its PayFi platform, which enables crypto-to-fiat and fiat-...
The global microbiology testing market is projected to grow rapidly at a compound annual growth rate (CAGR) of approximately 9% from 2026 to 2034, reaching a market size of $13.7 billion by 2034. This growth is driven by the rising prevalence of infe...
H.C. Wainwright raised its price target for Alector from $5.00 to $8.00, maintaining a Buy rating due to progress in its neurodegenerative disease pipeline. Alector develops treatments for Alzheimer's and Parkinson's using its Brain Carrier platform ...
